Delova Biotech
Latest round
- Series C
Last raised
- Jul 2026
Total raised
- $133M
Investors
- 23
About Delova Biotech
, trading as Delova Biotech, is a global biotechnology company focused on the research and development of novel drugs in the field of pain management. Its aim is to provide patients with non-opioid, long-acting, and potent analgesics. The founder and CEO of the company, Qingsong Wang, graduated from China Pharmaceutical University. The co-founder and CSO of the company, Ning Hu, graduated from the University of Southern California. The company focuses on the research and development of drugs in the field of pain management, and it has laid out nearly 10 non-opioid analgesics. It has developed several independent intellectual property technology products, such as extended and controlled release injection, topical transdermal technology, and solubility enhancement technology for insoluble drugs, which cover postoperative pain, aesthetic surgery pain, multiple neuropathic pains, osteoarthritis pain, migraine, and trigeminal neuralgia., Ltd. also focuses on the development of high-barrier innovative technology platforms such as long-acting injection technology, topical formulation transdermal technology, prodrug modification, etc. The company’s revenue is generated by the development and eventual commercialization of its proprietary drug formulations.
Who invested in Delova Biotech
23 investors across 4 rounds
See all investors in Delova Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Delova Biotech
Who invested in Delova Biotech?
Delova Biotech has 23 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Delova Biotech raised?
Delova Biotech has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Delova Biotech last raise money?
Delova Biotech's most recent round on record is a Series C, in Jul 2026.
What does Delova Biotech do?
, trading as Delova Biotech, is a global biotechnology company focused on the research and development of novel drugs in the field of pain management.
Where is Delova Biotech headquartered?
Delova Biotech is headquartered in Nanjing, China.
Which VCs invest in companies like Delova Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Delova Biotech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Delova Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.